Subcellular distribution of HP1 proteins is altered in ICF syndrome.
The Immunodeficiency, Centromeric instability, and Facial (ICF) syndrome is a rare autosomal recessive disorder that results from mutations in the DNMT3B gene, encoding a DNA-methyltransferase that acts on GC-rich satellite DNAs. This syndrome is characterized by immunodeficiency, facial dysmorphy, mental retardation of variable severity and chromosomal abnormalities that essentially involve juxtacentromeric heterochromatin of chromosomes 1 and 16. These abnormalities demonstrate that hypomethylation of satellite DNA can induce alterations in the structure of heterochromatin. In order to investigate the effect of DNA hypomethylation on heterochromatin organization, we analyzed the in vivo distribution of HP1 proteins, essential components of heterochromatin, in three ICF patients. We observed that, in a large proportion of ICF G2 nuclei, all HP1 isoforms show an aberrant signal concentrated into a prominent bright focus that co-localizes with the undercondensed 1qh or 16qh heterochromatin. We found that SP100, SUMO-1 and other proteins from the promyelocytic leukemia nuclear bodies (NBs) form a large body that co-localizes with the HP1 signal. This is the first description of altered nuclear distribution of HP1 proteins in the constitutional ICF syndrome. Our results show that satellite DNA hypomethylation does not prevent HP1 proteins from associating with heterochromatin. They suggest that, at G2 phase, HP1 proteins are involved in the heterochromatin condensation and may therefore remain concentrated at these sites until the condensation is complete. They also indicate that proteins from the NB could play a role in this process. Finally, satellite DNA length polymorphism could affect the efficiency of heterochromatin condensation and thus contribute to the variability of the ICF phenotype.
Inserm U 491, Faculté de Médecine, Marseille, France.
Judith J
JJ
Luciani
Danielle
D
Depetris
Chantal
C
Missirian
Cécile
C
Mignon-Ravix
Catherine
C
Metzler-Guillemain
André
A
Megarbane
Anne
A
Moncla
Marie-Geneviève
MG
Mattei
D002467:Cell Nucleus / Q000378:metabolism*; D002503:Centromere / Q000235:genetics*; D002675:Child, Preschool; D000090266:Chromobox Protein Homolog 5; D002868:Chromosomal Proteins, Non-Histone / Q000235:genetics*; D002869:Chromosome Aberrations; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D002885:Chromosomes, Human, Pair 16 / Q000235:genetics; D019175:DNA Methylation; D004276:DNA, Satellite / Q000378:metabolism*; D005145:Face / Q000002:abnormalities*; D005260:Female; D016195:G2 Phase; D006570:Heterochromatin / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000235:genetics*; D017404:In Situ Hybridization, Fluorescence; D007223:Infant; D007621:Karyotyping; D015473:Leukemia, Promyelocytic, Acute / Q000235:genetics; D009154:Mutation / Q000235:genetics; D020033:Protein Isoforms; D013577:Syndrome
D002868:Chromosomal Proteins, Non-Histone; D004276:DNA, Satellite; D006570:Heterochromatin; D020033:Protein Isoforms; D000090266:Chromobox Protein Homolog 5